These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6957896)

  • 1. Reduced presynaptic dopamine receptor density after chronic antidepressant treatment in rats.
    Lee T; Tang SW
    Psychiatry Res; 1982 Aug; 7(1):111-9. PubMed ID: 6957896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chronic antidepressant treatment on dopamine-related [3H]SCH 23390 and [3H]spiperone binding in the rat striatum.
    Paetsch PR; Greenshaw AJ
    Cell Mol Neurobiol; 1992 Dec; 12(6):597-606. PubMed ID: 1490276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of effect of chronic desipramine treatment on dopaminergic activity in the nucleus accumbens of the rat.
    Reyneke L; Allin R; Russell VA; Taljaard JJ
    Neurochem Res; 1989 Jul; 14(7):661-5. PubMed ID: 2571096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding characteristics of the dopamine uptake inhibitor [3H]nomifensine to striatal membranes.
    Dubocovich ML; Zahniser NR
    Biochem Pharmacol; 1985 Apr; 34(8):1137-44. PubMed ID: 3158318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomifensine-induced increase in extracellular striatal dopamine is enhanced by isoflurane anaesthesia.
    Opacka-Juffry J; Ahier RG; Cremer JE
    Synapse; 1991 Feb; 7(2):169-71. PubMed ID: 2011829
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
    Hilakivi I; Rinne J; Marjamäki P
    Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of inhibitory activity of sulpiride for synaptic [3H]-spiperone binding in the rat striatum.
    Oki K; Nomura Y
    Dev Neurosci; 1982; 5(4):379-84. PubMed ID: 7140585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different adaptive responses by rat striatal dopamine synthetic and receptor mechanisms after repeated treatment with d-amphetamine, methylphenidate and nomifensine.
    Algeri S; Brunello N; Vantini G
    Pharmacol Res Commun; 1980 Jul; 12(7):675-81. PubMed ID: 6105682
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic haloperidol does not alter agonist affinity for dopamine receptors in vitro.
    Meller E; Bohmaker K; Goldstein M; Schweitzer JW; Friedhoff AJ
    Eur J Pharmacol; 1985 Mar; 109(3):389-94. PubMed ID: 3157587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of [3H]dopamine into dopaminergic and noradrenergic neurones of the isolated neurointermediate lobe of the rat hypophysis. Effects of desipramine and nomifensine.
    Racké K; Muscholl E
    J Neurochem; 1983 Nov; 41(5):1488-91. PubMed ID: 6619880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chronic nicotine treatment and withdrawal on rat striatal D1 and D2 dopamine receptors.
    Kirch DG; Taylor TR; Creese I; Xu SX; Wyatt RJ
    J Pharm Pharmacol; 1992 Feb; 44(2):89-92. PubMed ID: 1352822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo effects of benztropine and nomifensine on dopamine and noradrenaline terminals in rat brain.
    Broch OJ
    Eur J Pharmacol; 1979 Oct; 58(4):419-24. PubMed ID: 510376
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of subacute treatment with toluene on central monoamine receptors in the rat. Reduced affinity in [3H]5-hydroxytryptamine binding sites and in [3H]spiperone binding sites linked to dopamine receptors.
    Celani MF; Fuxe K; Agnati LF; Andersson K; Hansson T; Gustafsson JA; Battistini N; Eneroth P
    Toxicol Lett; 1983 Jul; 17(3-4):275-81. PubMed ID: 6623522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that [3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro.
    Kelly E; Jenner P; Marsden CD
    J Neurochem; 1985 Jul; 45(1):137-44. PubMed ID: 3923157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain.
    Seeman P; Guan HC; Niznik HB
    Synapse; 1989; 3(1):96-7. PubMed ID: 2521961
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of buflomedil (4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxy phenyl)-1-butanone hydrochloride) on the function of striatal dopaminergic neurons.
    Koda H; Hashimoto T; Kuriyama K
    Jpn J Pharmacol; 1989 Feb; 49(2):215-23. PubMed ID: 2659861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro characterisation of dopamine receptors in the superior colliculus of the rat.
    Weller ME; Rose S; Jenner P; Marsden CD
    Neuropharmacology; 1987 Apr; 26(4):347-54. PubMed ID: 2438586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reversal effect of antidepressants on the escape deficit induced by inescapable shock in rats.
    Kametani H; Nomura S; Shimizu J
    Psychopharmacology (Berl); 1983; 80(3):206-8. PubMed ID: 6310665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated administration of HA-966 and haloperidol to rats: similar tolerance to striatal dopamine accumulation after HA-966 challenge, but dissimilar effects on striatal [3H]spiperone binding.
    Van der Krogt JA; Van Valkenburg CF; Belfroid RD; Heerkens CB
    Eur J Pharmacol; 1988 Dec; 158(1-2):29-35. PubMed ID: 3220118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.